157 related articles for article (PubMed ID: 36736290)
1. Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.
Sebert M; Gachet S; Leblanc T; Rousseau A; Bluteau O; Kim R; Ben Abdelali R; Sicre de Fontbrune F; Maillard L; Fedronie C; Murigneux V; Bellenger L; Naouar N; Quentin S; Hernandez L; Vasquez N; Da Costa M; Prata PH; Larcher L; de Tersant M; Duchmann M; Raimbault A; Trimoreau F; Fenneteau O; Cuccuini W; Gachard N; Auger N; Tueur G; Blanluet M; Gazin C; Souyri M; Langa Vives F; Mendez-Bermudez A; Lapillonne H; Lengline E; Raffoux E; Fenaux P; Adès L; Forcade E; Jubert C; Domenech C; Strullu M; Bruno B; Buchbinder N; Thomas C; Petit A; Leverger G; Michel G; Cavazzana M; Gluckman E; Bertrand Y; Boissel N; Baruchel A; Dalle JH; Clappier E; Gilson E; Deriano L; Chevret S; Sigaux F; Socié G; Stoppa-Lyonnet D; de Thé H; Antoniewski C; Bluteau D; Peffault de Latour R; Soulier J
Cell Stem Cell; 2023 Feb; 30(2):153-170.e9. PubMed ID: 36736290
[TBL] [Abstract][Full Text] [Related]
2. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
[TBL] [Abstract][Full Text] [Related]
3. MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma.
Hüllein J; Słabicki M; Rosolowski M; Jethwa A; Habringer S; Tomska K; Kurilov R; Lu J; Scheinost S; Wagener R; Huang Z; Lukas M; Yavorska O; Helfrich H; Scholtysik R; Bonneau K; Tedesco D; Küppers R; Klapper W; Pott C; Stilgenbauer S; Burkhardt B; Löffler M; Trümper LH; Hummel M; Brors B; Zapatka M; Siebert R; Kreuz M; Keller U; Huber W; Zenz T
Cancer Res; 2019 Jun; 79(12):3125-3138. PubMed ID: 31000522
[TBL] [Abstract][Full Text] [Related]
4. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
Venkatraj VS; Gaidano G; Auerbach AD
Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
[TBL] [Abstract][Full Text] [Related]
5. p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes.
Rakotopare J; Toledo F
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834388
[TBL] [Abstract][Full Text] [Related]
6. p53-TP53-Induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells.
Li X; Wu L; Zopp M; Kopelov S; Du W
Stem Cells; 2019 Jul; 37(7):937-947. PubMed ID: 30977208
[TBL] [Abstract][Full Text] [Related]
7. Clonal hematopoiesis in the inherited bone marrow failure syndromes.
Tsai FD; Lindsley RC
Blood; 2020 Oct; 136(14):1615-1622. PubMed ID: 32736377
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
[TBL] [Abstract][Full Text] [Related]
9. MYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia.
Rodríguez A; Zhang K; Färkkilä A; Filiatrault J; Yang C; Velázquez M; Furutani E; Goldman DC; García de Teresa B; Garza-Mayén G; McQueen K; Sambel LA; Molina B; Torres L; González M; Vadillo E; Pelayo R; Fleming WH; Grompe M; Shimamura A; Hautaniemi S; Greenberger J; Frías S; Parmar K; D'Andrea AD
Cell Stem Cell; 2021 Jan; 28(1):33-47.e8. PubMed ID: 32997960
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetics in Fanconi Anemia: The Importance of Follow-Up and the Search for New Biomarkers of Genomic Instability.
Merfort LW; Lisboa MO; Cavalli LR; Bonfim CMS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430597
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of TGFβ1 and TGFβ3 promotes hematopoiesis in Fanconi anemia.
Rodríguez A; Yang C; Furutani E; García de Teresa B; Velázquez M; Filiatrault J; Sambel LA; Phan T; Flores-Guzmán P; Sánchez S; Monsiváis Orozco A; Mayani H; Bolukbasi OV; Färkkilä A; Epperly M; Greenberger J; Shimamura A; Frías S; Grompe M; Parmar K; D'Andrea AD
Exp Hematol; 2021 Jan; 93():70-84.e4. PubMed ID: 33166613
[TBL] [Abstract][Full Text] [Related]
12. The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation.
Du W; Amarachintha S; Erden O; Wilson A; Pang Q
Oncotarget; 2016 Sep; 7(37):60005-60020. PubMed ID: 27507053
[TBL] [Abstract][Full Text] [Related]
13. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis.
Freie B; Li X; Ciccone SL; Nawa K; Cooper S; Vogelweid C; Schantz L; Haneline LS; Orazi A; Broxmeyer HE; Lee SH; Clapp DW
Blood; 2003 Dec; 102(12):4146-52. PubMed ID: 12855557
[TBL] [Abstract][Full Text] [Related]
14. A small molecule p53 activator attenuates Fanconi anemia leukemic stem cell proliferation.
Du W; Li X; Wilson AF; Pang Q
Stem Cell Res Ther; 2018 May; 9(1):145. PubMed ID: 29784053
[TBL] [Abstract][Full Text] [Related]
15. An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation.
Marion W; Boettcher S; Ruiz-Torres S; Lummertz da Rocha E; Lundin V; Morris V; Chou S; Zhao AM; Kubaczka C; Aumais O; Zhang Y; Shimamura A; Schlaeger TM; North TE; Ebert BL; Wells SI; Daley GQ; Rowe RG
Blood Adv; 2020 Oct; 4(19):4679-4692. PubMed ID: 33002135
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.
Ceccaldi R; Parmar K; Mouly E; Delord M; Kim JM; Regairaz M; Pla M; Vasquez N; Zhang QS; Pondarre C; Peffault de Latour R; Gluckman E; Cavazzana-Calvo M; Leblanc T; Larghero J; Grompe M; Socié G; D'Andrea AD; Soulier J
Cell Stem Cell; 2012 Jul; 11(1):36-49. PubMed ID: 22683204
[TBL] [Abstract][Full Text] [Related]
18. Leukemia and chromosomal instability in aged Fancc-/- mice.
Cerabona D; Sun Z; Nalepa G
Exp Hematol; 2016 May; 44(5):352-7. PubMed ID: 26860989
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage.
Tulpule A; Lensch MW; Miller JD; Austin K; D'Andrea A; Schlaeger TM; Shimamura A; Daley GQ
Blood; 2010 Apr; 115(17):3453-62. PubMed ID: 20089964
[TBL] [Abstract][Full Text] [Related]
20. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
Yamashita T; Nakahata T
Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
